Diwan B A, Ohshima M, Rice J M
Biological Carcinogenesis Development Program, Program Resources, Inc.; Frederick, MD.
IARC Sci Publ. 1989(96):75-80.
Prenatal administration of chemical carcinogens followed by postnatal application of tumour promoters can result in tumour formation at sites where no tumours would occur in the absence of promotion. Three different epithelia in mice and rats have been shown to be susceptible to transplacental initiation by N-nitroso compounds or polynuclear aromatic hydrocarbons, yielding potentially neoplastic cells in fetal tissues which can remain latent indefinitely until stimulated to proliferate by postnatal exposure to a promoting agent. These include epidermal squamous epithelium in mice, renal cortical epithelium in mice, and thyroid follicular epithelium in both mice and rats. The fact that effective promoters of carcinogenesis in nonsquamous epithelia include drugs such as phenobarbital that are administered to humans in high doses for prolonged periods suggests that prenatal initiation followed by postnatal promotion may pose significant risks for humans, and should be considered in designing epidemiological searches for etiological factors that contribute to the incidence of epithelial tumours in man.
产前给予化学致癌物,产后应用肿瘤促进剂,可导致在无促进作用时不会发生肿瘤的部位形成肿瘤。已证明,小鼠和大鼠的三种不同上皮组织易受经胎盘的亚硝基化合物或多环芳烃引发作用的影响,在胎儿组织中产生潜在的肿瘤细胞,这些细胞可无限期潜伏,直到产后接触促进剂刺激其增殖。这些组织包括小鼠的表皮鳞状上皮、小鼠的肾皮质上皮以及小鼠和大鼠的甲状腺滤泡上皮。非鳞状上皮中致癌作用的有效促进剂包括苯巴比妥等药物,这些药物在高剂量下长期给予人类,这一事实表明产前引发随后产后促进可能对人类构成重大风险,在设计针对导致人类上皮肿瘤发病率的病因因素的流行病学研究时应予以考虑。